Innate Pharma buy metanicnor
Start price
07.09.14
/
50%
€8.63
Target price
09.03.15
€10.50
Performance (%)
19.99%
End price
09.03.15
€10.35
Summary
This prediction ended on 09.03.15 with a price of €10.35. The prediction had a final performance of 19.99%. metanicnor has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Innate Pharma | 1.246% | 1.246% | -3.941% | -27.239% |
| iShares Core DAX® | -0.099% | 1.027% | 31.262% | 81.137% |
| iShares Nasdaq 100 | -1.085% | 2.134% | 14.536% | 56.321% |
| iShares Nikkei 225® | -0.835% | 8.556% | 5.546% | 19.511% |
| iShares S&P 500 | 0.099% | 2.881% | 11.163% | 37.432% |
Comments by metanicnor for this prediction
In the thread Innate Pharma diskutieren
IPH Kauf
eines der wenigen Biotech-Unternehmen in der Welt auf der angeborenen Immunität positioniert
das Geld wird es ermöglichen, halten die Ende 2017
(Laufzeit überschritten)